| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 1.59 Billion |
| Market Size (2030) | USD 2.66 Billion |
| CAGR (2025 - 2030) | 10.88 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Genetic Toxicology Testing Market Analysis
The Genetic Toxicology Testing Market size is estimated at USD 1.59 billion in 2025, and is expected to reach USD 2.66 billion by 2030, at a CAGR of 10.88% during the forecast period (2025-2030).
Genetic toxicology testing plays a critical role in risk assessment by providing data on the genotoxic potential of substances. This information is used to evaluate the risks associated with exposure to chemicals and make informed decisions regarding their use and regulation.
The rising incidence of cancer, technological advancements in genomics, active R&D in pharmaceuticals, and biotechnology companies, a shift towards personalized medicine and precision healthcare, and heightened awareness of health hazards linked to genotoxic agent exposure are driving the market growth.
An article published by Elsevier in February 2022 highlighted the importance of toxicity testing in drug discovery and research.Toxicity testing plays an essential role in identifying the potential adverse effects caused by chemicals. For instance, genotoxicity and immunotoxicity in humans are generally observed after chronic chemical exposure. So, toxicity testing is required to assess a chemical or drug candidate's hazard. The emphasis on toxicity testing in drug discovery and research, as highlighted in the article, underscores the critical role of assessing potential adverse effects caused by chemicals, including genotoxicity and immunotoxicity. The need to evaluate the hazards posed by chemical compounds and drug candidates drives the demand for genetic toxicology testing and influences the genetic toxicology testing market.
Moreover, the increasing initiatives taken by the market players to support the development of novel therapeutics is also fueling the growth of the market. For instance, in July 2022, Inotiv, Inc. announced that the company has greatly expanded its capacity in Rockville and North Carolina of the United States sites to conduct good laboratory practices studies for in vitro cytogenetics and bacterial mutation assays as components of the standard battery of genetic toxicology studies required to support first-in-human evaluations of novel therapeutics.
Therefore, increasing emphasis on toxicity testing in drug discovery and research, the rise in demand for toxicology drug screening in the pharmaceutical and biotechnology industries are expected to contribute to the market growth during the analysis period. However, the long duration of sample testing and stringent government regulations on the genetic toxicology testing of human drug molecules are expected to hinder market growth over the forecast period.
Genetic Toxicology Testing Market Trends
Assays Kits Segment is Expected to Dominate the Genetic Toxicology Testing Market During the Forecast Period
Assays kits offer standardized protocols and reagents, making them user-friendly and ensuring consistent results across different laboratories. This ease of use and standardization contribute to their widespread adoption in genetic toxicology testing. Moreover, assay kits often provide a cost-effective solution compared to developing and validating in-house assays. The affordability of these kits makes them a preferred choice for researchers and laboratories conducting genotoxicity testing. All these factors are likely to drive the segment growth during the forecast period.
Additionally, the initiatives taken by the market players to meet the increasing demand for genetic toxicology testing through assay kits by biopharmaceutical companies demonstrate the high potential for growth in the studied market segment. For instance, in September 2024, Mutagentech and Toxys collaboratively launched MutaTracker, an assay to test the mutagenicity and genotoxicity of compounds and chemicals used in the pharmaceutical, chemical, and cosmetic industries with exceptional accuracy and sensitivity.
Similarly, in September 2024, Scantox acquired Gentronix Ltd, a UK based GLP compliant genetic toxicology contract research organization. Gentronix Ltd have the Big Blue assay, one of only three tests in the world used for the final assessment of potential mutagenicity. Gentronix has provided genetic toxicology solutions to the global pharma, biotech and agrichem industries.
Thus, such initiatives demonstrated there is a high demand for assays kit to perform genetic toxicology testing and the benefit of assays kit in conducting genotoxicity testing fuels the growth of the market segment over the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America Region is Expected to Dominate the Genetic Toxicology Testing Market During the Forecast Period
North America is expected to hold a significant market share in the global genetic toxicology testing market. Factors such as the rise in demand for toxicology drug screening in pharmaceuticals and biotechnology in the region are fueling the market growth in the country.
The presence of a well-established pharmaceutical industry in the region, the high R&D expenditure, and the strong presence of major service providers in the region are several major factors that contribute to the overall market growth. For instance, in July 2024, data released by the American Journal of Health-System Pharmacy revealed that in 2023, the United States spent USD 722.5 billion on pharmaceutical products, a 13.6% increase from 2022. This increase in expenditure is primarily driven by the focus on having the edge over their competitors and the rising demand for drugs to treat various diseases. The increased pharmaceutical expenditure reflects a higher investment in research and development (R&D) for drug discovery. Companies prioritize genetic toxicology testing to assess the safety profiles of drug candidates, ensuring regulatory compliance and reducing the risks of adverse effects. This drives the demand for the genetic toxicology testing market in the region.
Moreover, strategic activity such as acquisiton to server the growing demand for genetic toxicology testing is also likely to drive the market growth in the region. For instance, in Januray 2022, Inotiv Inc., with the acquisition of North Carolina-based Integrated Laboratory Systems, LLC, the company expanded its GLP safety assessment offerings for in vivo and in vitro general and genetic toxicology services in the United States.
Thus, the above mentioned factors is likeyto drive the genetic toxicology testing market in the North America region.
Get Analysis on Important Geographic Markets
Download PDF
Genetic Toxicology Testing Industry Overview
The genetic toxicology testing market is moderately competitive and consists of a few major players. Companies, like Eurofins Scientific,WuXi AppTec, Charles River Laboratories, and Laboratory Corporation of America Holdings hold substantial market shares in the genetic toxicology testing market. New product developments, acquisitions, collaborations, and regional expansions are some of the key strategic initiatives undertaken by major players to maintain stability in the market.
Genetic Toxicology Testing Market Leaders
-
Eurofins Scientific
-
WuXi AppTec
-
Charles River Laboratories
-
Frontage Labs
-
Laboratory Corporation of America Holdings
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Genetic Toxicology Testing Market News
- January 2023: In January 2023, Aegis Sciences Corporation acquired the toxicology line of business from HealthTrackRx. This strategic move enables Aegis to offer an even broader range of clinical toxicology testing services to a wider network of providers.
- November 2022: Instem, a provider of information and technology (IT) solutions and services to the global life sciences market, updated its Computational Toxicology Software Suite solution. The 2022 software update allows its clients to access more than 600,000 toxicology studies for more than 200,000 chemicals, enabling fast, accurate, defendable, and regulatory-accepted predictions.
Genetic Toxicology Testing Industry Segmentation
As per the scope of the report, genetic toxicology testing refers to evaluates the potential of chemicals, pharmaceuticals, or environmental substances to cause genetic damage. It is a key component of safety assessments, particularly in drug development, environmental monitoring, and regulatory compliance. This testing focuses on identifying substances that can cause mutations, chromosomal aberrations, or other alterations in genetic material, which may lead to cancer, heritable diseases, or other adverse effects.
The genetic toxicology testing market is segmented as products into reagents & consumables, assay kits, and services. By test type, the genetic toxicology testing market is segmented into in vitro genetic toxicology tests and in vivo genetic toxicology tests. In terms of end user, the market is segment into pharmaceuticals & biotechnology companies, food industry, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD) for the above segments.
| By Product Type | Reagents & Consumables | ||
| Assays Kit | |||
| Services | |||
| By Test Type | In Vitro Genetic Toxicology Tests | ||
| In Vivo Genetic Toxicology Test | |||
| By End User | Pharmaceutical and Biotechnoloy Companies | ||
| Food Industry | |||
| Others | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Genetic Toxicology Testing Market Research FAQs
How big is the Genetic Toxicology Testing Market?
The Genetic Toxicology Testing Market size is expected to reach USD 1.59 billion in 2025 and grow at a CAGR of 10.88% to reach USD 2.66 billion by 2030.
What is the current Genetic Toxicology Testing Market size?
In 2025, the Genetic Toxicology Testing Market size is expected to reach USD 1.59 billion.
Who are the key players in Genetic Toxicology Testing Market?
Eurofins Scientific, WuXi AppTec, Charles River Laboratories, Frontage Labs and Laboratory Corporation of America Holdings are the major companies operating in the Genetic Toxicology Testing Market.
Which is the fastest growing region in Genetic Toxicology Testing Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Genetic Toxicology Testing Market?
In 2025, the North America accounts for the largest market share in Genetic Toxicology Testing Market.
What years does this Genetic Toxicology Testing Market cover, and what was the market size in 2024?
In 2024, the Genetic Toxicology Testing Market size was estimated at USD 1.42 billion. The report covers the Genetic Toxicology Testing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Genetic Toxicology Testing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Genetic Toxicology Testing Industry Report
Statistics for the 2025 Genetic Toxicology Testing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Genetic Toxicology Testing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
